SLL Clinical Trials in Durham, North Carolina
3 recruitingDurham, North Carolina
Showing 1–3 of 3 trials
Recruiting
Phase 1
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
Nurix Therapeutics, Inc.572 enrolled62 locationsNCT05131022
Recruiting
Phase 1
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Diffuse Large B Cell LymphomaMantle Cell LymphomaFollicular Lymphoma+4 more
Newave Pharmaceutical Inc60 enrolled4 locationsNCT04775745
Recruiting
Phase 1
CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
SLLLymphocytic Leukemia, Chronic
Catapult Therapeutics18 enrolled4 locationsNCT04704323